// App-Quantinova.ai

THU0506 : CARDIOVASCULAR RISK AND ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH GOUT: EXPERIENCE IN A MULTIHOSPITAL SPANISH GROUP

Researchers

Presenter

  • E. Calvo Aranda

Principal Investigators

  • O. Carrion

  • A. Abdelkader

  • P. Garcia de la Pena

  • J. Gonzalez

  • F. Aramburu

  • M. Valero

  • S. Rodriguez

  • C. Marin

  • C. Sanguesa

  • I. Amil

  • F. Saiz

Medical Centers

  • Vascular Surgery, HM Hospitales, madrid, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Left ventricular hypertrophy

  • Vasodilation dysfunction

  • Coronary Artery Disease

  • Myocardial infarction

  • Vitamin D deficiency

  • Congestive heart failure

  • Progressive cardiac conduction defect

  • Gout

  • Dyslipidemia

  • Hypertension

  • Osteoporosis

  • Arrhythmia

  • Obesity

  • Venous thrombosis

  • Inflammatory Arthritis

  • Diabetes

  • Angina

  • Stroke

  • Gout/hyperuricemia

Biomarkers

  • Estrogen receptor alpha

  • High sensitivity C-reactive protein

  • Body mass index

Drug/Treatment

  • Angiotensin II

  • Ergocalciferol

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved